News
Altus Announces New European Abuse Deterrent Technology Patents
Altus Formulation Inc. Montreal Altus Formulation Inc. a Quebec – based drug formulation and development company, leveraging it’s patented drug delivery technologies to develop Safer to UseTM formulations for its partners and their patients is pleased to announce the...
Notice of Allowance in the USA for its new Patent entitled sustained drug release compositions
Montreal Altus Formulation Inc. a Quebec – based drug formulation and development company, leveraging it’s patented drug delivery technology to develop safer formulations for its partners and their patients is pleased to announce the Notice of Allowance in the USA...
Zogenix Pursues Development of Abuse Deterrent Formulations of Zohydro ER with Altus Formulation
SAN DIEGO – November 1, 2013 - Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, today announced that it has entered into a Development and Option Agreement...